containing myo - Inositol, amino acids, antioxidants and minerals for improving metabolic syndrome in men
metabolic sydrome is a cluster of conditions — increased blood pressure, a high blood sugar level, excess body fat around the waist and abnormal cholesterol levels. "metabolic syndrome is the name for a group of risk factors that raises your risk for heart disease and other health problems, such as diabetes and stroke. the term "metabolic" refers to the biochemical processes involved in the body's normal functioning." (source: 1)
containing myo - Inositol, amino acids, antioxidants and minerals for Fertility
it all starts with an healthy sperm. and of course a healthy egg. to become pregnant, a women needs a regular menstrual cycle, regular ovulation and a healthy oocyte (egg). and HE needs to have enough sperm of normal quality and activity. the celluar micro-environement in the testis and within the sperm is an important determinant of sperm development (source: 2). research found out that patients with necrozoospermia (all or a significant amount of sperm in the ejaculte is dead) did show an absence or extrem low concentrations of myo – Inositol in sperm. INOMAN® has specifically been designed to address several aspects of sub-fertility with its unique components. They improve
SPERM COUNT - with use of myo-inositol and antioxidants like in INOMAN® over three months, nearly all users improve their sperm count (in average they experienced a doubling of sperm)1.
SPERM MORPHOLOGY: with use of myo-inositol and antioxidants like in INOMAN® over three months, nearly all users improve their sperm morphology (in average by around 10%)1.
SPERM MOTILITY: with use of myo-inositol and antioxidants like in INOMAN® over three months, nearly all users improve their sperm motility (in average by almost 5O%)1.
2. Chiu T. et al. Follicular fluid and serum concentrations of Myo – Inositol in patients undergoing IVF: relationship with oocyte quality. Human Reproduction 2002;17(6): 1591-1596
3. Gerli S, Mignosa M, Di Renzo GC. Effects of inositol on ovarian function and metabolic factors in women with PCOS: a randomized double blind placebo-controlled trial. Eur Rev Med Pharmacol Sci. 2003;7(6):151–159
4. Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab. 1998;83(9): 3078–3082